The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
Open accessAbstract
MicroRNAs (miRNAs) are endogenous short non-coding RNAs that can regulate the expression of target genes post-transcriptionally and interact with mRNA-coding genes. MiRNAs play vital roles in many biological functions, and abnormal miRNA expression has been linked to various illnesses, including cancer. Among the miRNAs, miR-122, miR-206, miR-21, miR-210, miR-223, and miR-424 have been extensively studied in various cancers. Although research in miRNAs has grown considerably over the last decade, much is yet to be discovered, especially regarding their role in cancer therapies. Several kinds of cancer have been linked to dysregulation and abnormal expression of miR-122, indicating that miR-122 may serve as a diagnostic and/or prognostic biomarker for human cancer. Consequently, in this review literature, miR-122 has been analyzed in numerous cancer types to sort out the function of cancer cells miR-122 and enhance patient response to standard therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From this analysis, we selected the three abundant miRNAs-hsa-miR-122-5p, hsa-let-7a-5p, and hsa-miR26a-5p-based on their complementary and comprehensive coverage of almost all the critical genes associated with the MAPK signaling pathway 27-33 as analyzed using miRTarBase version 8.0 and TarBase v8.0 integrated within miRNet (Figure S1).”
From rAAV-mediated Multi-miRNA Delivery Targeting MAPK Pathway Suppresses Laser-induced Choroidal Neovascularization in Mice (2026) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
7 retracted
Sun, Y., Jin, J., Mi, W., Hao-Wu, Zhang, S., Meng, Q., & Zhang, S. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14934860122864 · Cited by 60
RetractedRETRACTED: MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer
Shirvani, H., Ghanavi, J., Aliabadi, A., Mousavinasab, F., Talebi, M., Majidpoor, J., Najafi, S., Miryounesi, S. M., & Zarch, S. M. A. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110504 · Cited by 48
Self-citationRetractedRETRACTED: MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
Ma, D., Jia, H., Qin, M., Dai, W., Wang, T., Liang, E., Dong, G., Wang, Z., Zhang, Z., & Feng, F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922137 · Cited by 47
RetractedmiR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Li, X.-N., Yang, H., & Yang, T. (2020) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504019x15615433287579 · Cited by 34
RetractedMicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.
Rao, M., Zhu, Y., Zhou, Y., Cong, X., & Li, F. (2017) · Europe PMC (PubMed Central) · Cited by 33
RetractedRETRACTED: MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro
Li, H., Zhang, X., Jin, Z. Y., Yin, T., Duan, C., Sun, J., Xiong, R., & Li, Z. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819871300 · Cited by 29
RetractedRETRACTED: Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance
Shirvani, H., Jafari, H., Moravveji, S. S., Faranghizadeh, F. A., Talebi, M., Ghanavi, J., Esfandi, F., Najafi, S., Moghadam, M. N., Farnia, P., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.105 · Cited by 20
Self-citationRetractedA microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Yang (2021) · doi:10.1038/s41598-020-79139-8 · Cited by 5,035
The role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,566
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118
Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E., & Thorgeirsson, S. S. (2009) · Oncogene · doi:10.1038/onc.2009.211 · Cited by 748
Lou, G., Song, X., Yang, F., Wu, S., Wang, J., Chen, Z., & Liu, Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0220-7 · Cited by 651
Wang, X., Zhang, H., Yang, H., Bai, M., Ning, T., Deng, T., Liu, R., Fan, Q., Zhu, K., Li, J., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12629 · Cited by 492
Liver-specific microRNA-122: Biogenesis and function
Jopling, C. L. (2012) · RNA Biology · doi:10.4161/rna.18827 · Cited by 433
Long, J.-K., Dai, W., Zheng, Y.-W., & Zhao, S.-P. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0085-2 · Cited by 281
MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R
Wang, B., Wang, H., & Yang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047053 · Cited by 169
Cheng, D., Deng, J., Zhang, B., He, X., Meng, Z., Li, G., Ye, H., Zheng, S., Wei, L., Deng, X., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.055 · Cited by 167
From structures to functions: insights into exosomes as promising drug delivery vehicles
Ren, J., He, W., Zheng, L., & Duan, H. (2016) · Biomaterials Science · doi:10.1039/c5bm00583c · Cited by 164
Su, R., Cao, S., Ma, J., Liu, Y., Liu, X., Zheng, J., Chen, J., Liu, L., Cai, H., Li, Z., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0737-1 · Cited by 153
Xu, Y., Huang, J., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, L., Luo, Y., Yao, C., & Qian, C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.11.034 · Cited by 148
Ma, L., Liu, J., Shen, J., Liu, L., Wu, J., Li, W., Luo, J., Chen, Q., & Qian, C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.7.11267 · Cited by 148
Regulation and biological function of the liver-specific miR-122
Lewis, A., & Jopling, C. L. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381553 · Cited by 144
Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122
Song, K., Kwon, H., Han, C., Zhang, J., Dash, S., Lim, K., & Wu, T. (2015) · Oncotarget · doi:10.18632/oncotarget.5812 · Cited by 125
Yin, Z., Zhou, Y., Ma, T.-T., Chen, S., Shi, N., Zou, Y.-P., Hou, B., & Zhang, C. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15125 · Cited by 116
Recent trends in targeting miRNAs for cancer therapy
Shah, V., & Shah, J. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13351 · Cited by 116
Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis
Zhao, X., Liu, M., & Li, D. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2228-7 · Cited by 112
Sun, L., Liu, X., Pan, B., Hu, X., Zhu, Y., Su, Y., Guo, Z., Zhang, G., Xu, M., Xu, X., et al. (2019) · Journal of Cancer · doi:10.7150/jca.33022 · Cited by 110
Plasma miR‐122 and miR‐200 family are prognostic markers in colorectal cancer
Maierthaler, M., Benner, A., Hoffmeister, M., Surowy, H., Jansen, L., Knebel, P., Chang-Claude, J. C., Brenner, H., & Burwinkel, B. (2016) · International Journal of Cancer · doi:10.1002/ijc.30433 · Cited by 106
Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
Heinemann, F. G., Tolkach, Y., Deng, M. C.-H. K., Schmidt, D. H., Perner, S., Kristiansen, G., Müller, S. C., & Ellinger, J. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0444-9 · Cited by 97
Resveratrol chemosensitizes adriamycin‐resistant breast cancer cells by modulating miR‐122‐5p
Zhang, W., Jiang, H., Chen, Y., & Ren, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28910 · Cited by 95
Chen, Q., Ge, X., Zhang, Y., Xia, H., Yuan, D., Tang, Q., Chen, L., PANG, X., Leng, W., & Bi, F. (2014) · Oncology Reports · doi:10.3892/or.2014.3004 · Cited by 94
MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4
Xu, X., Gao, F., Wang, J., Tao, L., Ye, J., Li, D., Ji, W., & Chen, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1423925 · Cited by 89
Pan, C., Wang, X., Shi, K., Zheng, Y., Li, J., Chen, Y., Jin, L., & Pan, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152090 · Cited by 83
Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis
Sendi, H., Yazdimamaghani, M., Hu, M., Sultanpuram, N., Wang, J., Moody, A. S., McCabe, E., Zhang, J., Graboski, A. L., Li, L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2269 · Cited by 81
Zeinali, F., Zarch, S. M. A., Jahan-Mihan, A., Kalantar, S. M., Mehrjardi, M. Y. V., Fallahzadeh, H., Hosseinzadeh, M., Rahmanian, M., & Mozaffari–Khosravi, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251697 · Cited by 77
MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.
Wang, Y., Xing, Q., Liu, X., Guo, Z., Li, C., & Sun, G. (2016) · Europe PMC (PubMed Central) · Cited by 76
Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
O’Neill, C. P., & Dwyer, R. (2020) · Cells · doi:10.3390/cells9020521 · Cited by 75
Perez‐Añorve, I. X., la Rosa, C. H. G.-D., Soto‐Reyes, E., Beltrán‐Anaya, F. O., Moral-Hernández, Ó. D., Salgado-Albarrán, M., Angeles‐Zaragoza, O., González-Barrios, J. A., Landero‐Huerta, D. A., Chávez‐Saldaña, M., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12483 · Cited by 72
Najafi, S., Khatami, S. H., Khorsand, M., Jamali, Z., Shabaninejad, Z., Moazamfard, M., Majidpoor, J., Zarch, S. M. A., & Movahedpour, A. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113294 · Cited by 72
Self-citationBarajas, J. M., Reyes, R., Guerrero, M. J., Jacob, S. T., Motiwala, T., & Ghoshal, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-27358-5 · Cited by 71
Zhang, H., Zhang, F., Li, H., Liu, Y., Du, G.-Y., & Huang, Y. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.03.031 · Cited by 70
Li, C., Qin, F., Wang, W., Ni, Y., Gao, M., Guo, M., & Sun, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312866 · Cited by 69
The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle
Kunden, R. D., Khan, J. Q., Ghezelbash, S., & Wilson, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165677 · Cited by 68
The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer
Ergün, S., Ulaşlı, M., İğci, Y. Z., İğci, M., Kırkbeş, S., Borazan, E., Balik, A. A., Yumrutaş, Ö., Camcı, C., Çakmak, E. A., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3793-2 · Cited by 66
Cao, F., & Yin, L. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.10.009 · Cited by 63
MiR‐122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells
Duan, Y., Dong, Y., Dang, R., Hu, Z., Yang, Y., Hu, Y., & Cheng, J. (2018) · Cell Biology International · doi:10.1002/cbin.11052 · Cited by 63
Wang, Z., & Wang, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29188 · Cited by 60
Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis
Yin, S., Fan, Y., Zhang, H., Zhao, Z., Hao, Y., Li, J., Sun, C., Yang, J., Yang, Z., Yang, X. Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11012 · Cited by 59
Loosen, S. H., Lurje, G., Wiltberger, G. J., Vucur, M., Koch, A. H., Kather, J. N., Paffenholz, P., Tacke, F., Ulmer, T. F., Trautwein, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210944 · Cited by 59
miR‐122 promotes metastasis of clear‐cell renal cell carcinoma by downregulating Dicer
Yang, F., Ma, X., Li, H., Gao, Y., Huang, Q., Zhang, Y., Bao, X., Du, Q., Luo, G., Liu, K., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31050 · Cited by 59
Okuyama, S., Marusawa, H., Matsumoto, T., Ueda, Y., Matsumoto, Y. M., Endo, Y., Takai, A., & Chiba, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.26114 · Cited by 58
Yin, W., Xu, J., Li, C., Dai, X., Wu, T., & Wen, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s238338 · Cited by 57
Recent insights into the roles of circular RNAs in human brain development and neurologic diseases
Najafi, S., Zarch, S. M. A., Majidpoor, J., Pordel, S., Aghamiri, S., Rasul, M. F., Asemani, Y., Vakili, O., Mohammadi, V., Movahedpour, A., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.166 · Cited by 56
Self-citationGao, Z., Wang, Q., Ji, M., Guo, X., Li, L., & Su, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02872-9 · Cited by 55
Lian, J.-H., Wang, W., Wang, J., Zhang, Y., & Li, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5017 · Cited by 53
miR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression
Wang, G., Zhao, Y., & Zheng, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-2089-4 · Cited by 49
Xu, Z., Liu, G., Zhang, M., Zhang, Z., Jia, Y., Peng, L., Zhu, Y., Hu, J., Huang, R., & Sun, X. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492702 · Cited by 49
Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9
Qin, Q.-H., Yin, Z., Li, Y., Wang, B., & Zhang, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.066 · Cited by 48
miRNA ‐122‐5p in POI ovarian‐derived exosomes promotes granulosa cell apoptosis by regulating BCL9
Zhang, X., Zhang, R., Hao, J., Huang, X., Liu, M., Lv, M., Su, C., & Mu, Y. (2022) · Cancer Medicine · doi:10.1002/cam4.4615 · Cited by 48
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Turato, C., Fornari, F., Pollutri, D., Fassan, M., Quarta, S., Villano, G., Ruvoletto, M., Bolondi, L., Gramantieri, L., & Pontisso, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020171 · Cited by 47
Zhang, Y., & Tang, L. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0480-0 · Cited by 46
Gao, L., Chen, X., Wang, Y., & Zhang, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s236359 · Cited by 46
Dai, C., Zhang, Y., Xu, Z., & Jin, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01185-z · Cited by 46
Meng, L., Chen, Z., Jiang, Z., Huang, T., Hu, J., Luo, P.-Q., Zhang, H., Huang, M., Huang, L., Chen, Y., et al. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz141 · Cited by 45
Exosomal miR-122-5p inhibits tumorigenicity of gastric cancer by downregulating GIT1
Jiao, Y., Zhang, L., Li, J., He, Y., Zhang, X., & Li, J. (2021) · The International Journal of Biological Markers · doi:10.1177/1724600821990677 · Cited by 44
Cui, K., Jin, S., Du, Y., Yu, J., Han, F., Fan, Q., & Ma, W. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0922-y · Cited by 43
MicroRNA-206 in human cancer: Mechanistic and clinical perspectives.
Khasraghi, L. B., Nouri, M., Vazirzadeh, M., Hashemipour, N., Talebi, M., Zarch, F. A., Majidpoor, J., Kalhor, K., Farnia, P., Najafi, S., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110525 · Cited by 42
Self-citationMolecular biomarkers in diabetes mellitus (DM)
Zarch, S. M. A., Tezerjani, M. D., Talebi, M., & Mehrjardi, M. Y. V. (2020) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.34.28 · Cited by 41
Progress toward molecular therapy for diabetes mellitus: A focus on targeting inflammatory factors
Dehghan, M., Ghorbani, F., Najafi, S., Ravaei, N., Karimian, M., Kalhor, K., Movafagh, A., & Zarch, S. M. A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109945 · Cited by 41
Self-citationUen, Y., Wang, J.-W., Wang, C., Jhang, Y., Chung, J.-Y., Tseng, T., Sheu, M., & Lee, S.-C. (2018) · Oncotarget · doi:10.18632/oncotarget.25589 · Cited by 41
Chandimali, N., Huynh, D. L., Zhang, J., Lee, J. C., Yu, D., Jeong, D. K., & Kwon, T. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0050-1 · Cited by 41
Ding, F., Gao, B., Wu, X., Gong, C., Wang, W., & Zhang, S.-M. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12730 · Cited by 41
Gao, H., Qin, H., Sha, J., Jiang, C., Gao, X., Qu, L., Xu, T., Yan, H., & Qiyu, J. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s91696 · Cited by 40
Yuan, Y., Zhang, Y., Liu, B., Wu, H., Kang, Y., Li, M., Zeng, X. A., He, N., & Zhang, G. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0070-z · Cited by 37
Kong, L., Wu, Q., Zhao, L., Ye, J., Li, N., & Yang, H. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593647 · Cited by 37
Wang, S., Zheng, W., Ji, A., Zhang, D., & Zhou, M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s225742 · Cited by 36
miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma
Lu, W., Zhang, Y., Zhou, L., Wang, X., Mu, J., Jiang, L., Hu, Y., Dong, P., & Liu, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-4308-z · Cited by 36
Hua, Y., Zhu, Y., Zhang, J., Zhu, Z., Ning, Z., Chen, H., Liu, L., Chen, Z., & Meng, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495832 · Cited by 36
Xiong, Q., Bai, Y., Shi, R., Wang, J., Xu, W., Zhang, M., & Song, T. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.03.026 · Cited by 35
Pei, Z., Zhang, Z. G., Hu, A., Yang, F., & Gai, Y. (2017) · Die Pharmazie · doi:10.31083/ph.2017.6404 · Cited by 34
Dehghani, M., Zarch, S. M. A., Mehrjardi, M. Y. V., Nazari, M., Babakhanzadeh, E., Ghadimi, H., Zeinali, F., & Talebi, M. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.09.009 · Cited by 33
Major miRNA Involved in Insulin Secretion and Production in Beta-Cells
Zarch, S. M. A., Khodadadian, A., Karimi‐Nazari, E., Nazari, M., & Babakhanzadeh, E. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s249011 · Cited by 33
Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma
Tang, Y. C., Zhao, S., Wang, J., Li, D., Ren, Q., & Tang, Y. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2912-y · Cited by 31
Cochetti, G. G., Cari, L., Maulà, V., Cagnani, R., Paladini, A., Zingaro, M. D., Nocentini, G., & Mearini, E. E. (2022) · Cancers · doi:10.3390/cancers14051112 · Cited by 31
Gasmi, I., Machou, C., Rodrigues, A., Brouillet, A., Nguyen, T. C., Rousseau, B., Guillot, A., Rodriguez, C., Demontant, V., Ait-Ahmed, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70408 · Cited by 31
MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes
Zhang, Z. W., Li, H., Chen, S. S., Li, Y., Cui, Z., & Ma, J. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20165760 · Cited by 30
Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
Mazza, T., Gioffreda, D., Fontana, A., Biagini, T., Carella, M., Palumbo, O., Maiello, E., Bazzocchi, F., Andriulli, A., & Tavano, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00044 · Cited by 29
Yin, L., Keeler, G. D., Zhang, Y., Hoffman, B. E., Ling, C., Qing, K., & Srivastava, A. (2020) · Gene Therapy · doi:10.1038/s41434-020-0140-1 · Cited by 29
CREB1, a direct target of miR-122, promotes cell proliferation and invasion in bladder cancer
Guo, L., Yin, M., & Wang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9118 · Cited by 29
Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy
Guo, H., Xu, M. T., Cao, Z., Li, W., Chen, L., Xie, X., Wang, W., & Liu, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00983 · Cited by 29
Saleh, A. A., Soliman, S. E.-S., Habib, M. S. E., Gohar, S. F., & Abo-Zeid, G. S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04727-5 · Cited by 28
Qin, S., Ning, M., Liu, Q., Ding, X., Wang, Y., & Liu, Q. (2021) · Bioengineered · doi:10.1080/21655979.2021.1962685 · Cited by 28
miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer
Maruyama, S., Furuya, S., Shiraishi, K., Shimizu, H., Akaike, H., Hosomura, N., Kawaguchi, Y., Amemiya, H., Kawaida, H., Sudo, M., et al. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i10.344 · Cited by 26
MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2
Wang, Z., Qin, C., Zhang, J., Han, Z., Tao, J., Cao, Q., Zhou, W., Xu, Z., Zhao, C., Tan, R., et al. (2017) · Tumor Biology · doi:10.1177/1010428317691184 · Cited by 24
Shyu, Y., Lee, T., Lu, M., Chen, J.-R., Chien, R., Chen, H.-Y., Lin, J., Tsou, A., Chen, Y., Hsieh, C.-W., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0956-z · Cited by 24
Babakhanzadeh, E., Khodadadian, A., Nazari, M., Tezerjani, M. D., Zarch, S. M. A., Ghasemifar, S., Hosseinnia, M., & Mazaheri, M. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s255431 · Cited by 24
Circ_0072995 Promotes Ovarian Cancer Progression Through Regulating miR-122-5p/SLC1A5 Axis
Huang, X., Luo, Y., & Li, X. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10092-5 · Cited by 23
Yang, J., Yuan, Y., Yang, X., Hong, Z., & Yang, L. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.06.017 · Cited by 23
Li, A., Wu, J., Zhai, A., Qian, J., Wang, X., Qaria, M. A., Zhang, Q., Li, Y., Fang, Y., Kao, W., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4870 · Cited by 23
Lee, H. M., Wong, W. K. K., Fan, B., Lau, E. S. H., Hou, Y. J., Chun Kwan, O., Luk, A. O. Y., Chow, E., Ronald, C. W., Chan, J. C. N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03222-x · Cited by 22
MicroRNA‑122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2
Zhu, Z., Tang, G., & Yan, J. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9377 · Cited by 21
Yh, L., Jl, L., Wang, Z., Xh, Z., Xb, C., & Mq, W. (2019) · PubMed · doi:10.26355/eurrev_201901_16876 · Cited by 21
Zhu, H., Mi, Y., Jiang, X. L., Zhou, X., Li, R., Wei, Z., Jiang, H., Lu, J., & Sun, X. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2121-8 · Cited by 20
Kw, L., Sh, W., Wei, X., Yz, H., & Li, Z.-H. (2020) · PubMed · doi:10.26355/eurrev_202012_24163 · Cited by 20
Hu, X., Zhang, L., Tian, J., & Ma, J. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02232-3 · Cited by 20
Yuan, Q., Yu, H., Chen, J., Song, X., & Sun, L. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01174-2 · Cited by 19
Ma, W., Zhao, X., Xue, N., Gao, Y., & Xu, Q. (2021) · IUBMB Life · doi:10.1002/iub.2452 · Cited by 18
miR-122 Inhibits the Cervical Cancer Development by Targeting the Oncogene RAD21
Yang, Y., Liu, Y., Liu, W., Li, C., Liu, Y., Hu, W., & Song, H. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10098-z · Cited by 17
MiR-181b Expression Levels as Molecular Biomarker for Type 2 Diabetes
Zarch, S. M. A., Mehrjardi, M. Y. V., Babakhanzadeh, E., Nazari, M., Talebi, M., Zeniali, F., & Dehghani, M. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 16
Lowey, B., Hertz, L. M., Chiu, S., Valdez, K., Li, Q., & Liang, T. J. (2019) · mBio · doi:10.1128/mbio.01617-19 · Cited by 16
Akuta, N., Kawamura, Y., Suzuki, F., Saitoh, S., Arase, Y., Muraishi, N., Fujiyama, S., Sezaki, H., Hosaka, T., Kobayashi, M., et al. (2021) · Oncology · doi:10.1159/000519995 · Cited by 15
Liu, H., Hou, T., Ju, W., Xing, Y., Zhang, X., & Yang, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9995 · Cited by 14
Wang, J., Yu, P., Yu, J., Luo, J., Sun, Z., Sun, F., Kong, Z., & Wang, J.-L. (2021) · PubMed Central · Cited by 14
Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122
Zhou, K., Yan, Y., & Zhao, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-1768-5 · Cited by 13
Inhibition of apoptosis by miR‑122‑5p in α‑fetoprotein‑producing gastric cancer
Maruyama, S., Furuya, S., Shiraishi, K., Shimizu, H., Saito, R., Akaike, H., Hosomura, N., Kawaguchi, Y., Amemiya, H., Kawaida, H., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7023 · Cited by 12
LncRNA LINC00974 Downregulates miR-122 to Upregulate RhoA in Oral Squamous Cell Carcinoma
Tian, Y., Zhong, L., Gao, S.-L., Yu, Y., Sun, D., Liu, X., Ji, J., Yao, Y., Liu, Y., & Jiang, Z. (2019) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2019.2907 · Cited by 12
miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression
Hu, N., Tian, Y., Song, Y., & Zang, L. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12007 · Cited by 12
[miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
Li, J., Zhao, R., Fang, R., & Wang, J. (2018) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2018.11.14 · Cited by 10
Zhan, G., Jiang, H., Yang, R., & Yang, K. (2021) · PubMed Central · Cited by 9
Beg, M. M. A., Guru, S. A., Abdullah, S. M., Ahmad, I. S., Rizvi, A., Akhter, J., Goyal, Y., & Verma, A. K. (2021) · Oncology Research and Treatment · doi:10.1159/000518722 · Cited by 8
Research works printed but not linked: 1
- Shirvani H, Ghanavi J, Aliabadi A, Mousavinasab F, Talebi M, Majidpour J, et al. MiR-211 play dual regulatory role in cancer development: from tumor suppressor to tumor enhancer. Cell Signal. 2022;101:110504. · DOI
Cited by
Sorted by citations
RETRACTED: microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance
Fattahi, M., Shahrabi, S., Saadatpour, F., Rezaee, D., Beyglu, Z., Delavari, S., Amrolahi, A., Ahmadi, S., Bagheri‐Mohammadi, S., Noori, E., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125863 · Cited by 75
Self-citationRetractedRezaee, D., Saadatpour, F., Akbari, N., Zoghi, A., Najafi, S., Beyranvand, P., Rarani, F. Z., Rashidi, M. A., Bagheri‐Mohammadi, S., & Bakhtiari, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102090 · Cited by 76
Self-citationAn interplay between non-coding RNAs and gut microbiota in human health
Fardi, F., Khasraghi, L. B., Shahbakhti, N., Naseriyan, A. S., Najafi, S., Sanaaee, S., Alipourfard, I., Zamany, M., Karamipour, S., Jahani, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110739 · Cited by 60
Self-citationNon-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
Huang, C., Azizi, P., Vazirzadeh, M., Zarch, S. M. A., Aghaei-Zarch, F., Ghanavi, J., & Farnia, P. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04510-y · Cited by 56
Self-citationZaki, M. B., Abulsoud, A. I., Elshaer, S. S., Fathi, D., Abdelmaksoud, N. M., El‐Mahdy, H. A., Ismail, A., Elsakka, E. G. E., Sallam, A.-A. M., & Doghish, A. S. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154437 · Cited by 53
Metadata
- Authors
- Faramin Lashkarian, M., Hashemipour, N., Niaraki, N., Soghala, S., Moradi, A., Sarhangi, S., Hatami, M., Aghaei-Zarch, F., Khosravifar, M., Mohammadzadeh, A., Najafi, S., Majidpoor, J., Farnia, P., & Aghaei-Zarch, S. M.
- Affiliations
- Yazd University (IR)
- Shahid Beheshti University (IR)
- Islamic Azad University, Tehran (IR)
- Kerman University of Medical Sciences (IR)
- University of Pennsylvania (US)
- Gonabad University of Medical Sciences (IR)
- Masih Daneshvari Hospital (IR)
- Corresponding author
- Aghaei-Zarch, Fatemehsadat
- Najafi, Sajad
- Majidpoor, Jamal
- Farnia, Poopak
- ORCID
- Venue
- Cancer Cell International
- Published
- 2023-02-20
- Volume
- 23
- Issue
- 1
- Pages
- 29-29
- ISSN
- 1475-2867 (ISSN-L)
- PMC
- PMC9940444
- OpenAlex
- W4321371253
- Cited by
- 105
- References
- 121
- Citations by year
- 2026: 9 · 2025: 36 · 2024: 30 · 2023: 30
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cancer Cell International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- miR-122, microRNA, cancer, post-transcriptional regulation, microRNA dysregulation, diagnostic biomarkers, prognostic factors, cancer therapy response, miR-21, miR-210, miR-223, miR-424, miR-206
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
